BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30879862)

  • 1. Design and synthesis of a novel 1H-pyrrolo[3,2-b]pyridine-3-carboxamide derivative as an orally available ACC1 inhibitor.
    Mizojiri R; Nii N; Asano M; Sasaki M; Satoh Y; Yamamoto Y; Sumi H; Maezaki H
    Bioorg Med Chem; 2019 Jun; 27(12):2521-2530. PubMed ID: 30879862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Novel Selective Acetyl-CoA Carboxylase (ACC) 1 Inhibitors.
    Mizojiri R; Asano M; Tomita D; Banno H; Nii N; Sasaki M; Sumi H; Satoh Y; Yamamoto Y; Moriya T; Satomi Y; Maezaki H
    J Med Chem; 2018 Feb; 61(3):1098-1117. PubMed ID: 29232514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of a monocyclic derivative as a selective ACC1 inhibitor by chemical modification of biphenyl ACC1/2 dual inhibitors.
    Mizojiri R; Tomita D; Sasaki M; Satoh Y; Yamamoto Y; Sumi H; Maezaki H
    Bioorg Med Chem; 2021 Apr; 35():116056. PubMed ID: 33607488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification and pharmacological evaluation of potent, selective and orally available ACC1 inhibitor.
    Mizojiri R; Asano M; Sasaki M; Satoh Y; Yamamoto Y; Sumi H; Maezaki H
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126749. PubMed ID: 31672259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of novel spiro-pentacylamides as acetyl-CoA carboxylase inhibitors.
    Wei Q; Mei L; Yang Y; Ma H; Chen H; Zhang H; Zhou J
    Bioorg Med Chem; 2018 Aug; 26(14):3866-3874. PubMed ID: 30049586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats.
    Bengtsson C; Blaho S; Saitton DB; Brickmann K; Broddefalk J; Davidsson O; Drmota T; Folmer R; Hallberg K; Hallén S; Hovland R; Isin E; Johannesson P; Kull B; Larsson LO; Löfgren L; Nilsson KE; Noeske T; Oakes N; Plowright AT; Schnecke V; Ståhlberg P; Sörme P; Wan H; Wellner E; Oster L
    Bioorg Med Chem; 2011 May; 19(10):3039-53. PubMed ID: 21515056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3.
    Nakajima Y; Inoue T; Nakai K; Mukoyoshi K; Hamaguchi H; Hatanaka K; Sasaki H; Tanaka A; Takahashi F; Kunikawa S; Usuda H; Moritomo A; Higashi Y; Inami M; Shirakami S
    Bioorg Med Chem; 2015 Aug; 23(15):4871-4883. PubMed ID: 26071372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent biphenyl- and 3-phenyl pyridine-based inhibitors of acetyl-CoA carboxylase.
    Haque TS; Liang N; Golla R; Seethala R; Ma Z; Ewing WR; Cooper CB; Pelleymounter MA; Poss MA; Cheng D
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5872-6. PubMed ID: 19740659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and structure-activity relationships of novel spiro-piperidines as acetyl-CoA carboxylase inhibitors.
    Kamata M; Yamashita T; Kina A; Funata M; Mizukami A; Sasaki M; Tani A; Funami M; Amano N; Fukatsu K
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3643-7. PubMed ID: 22560583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-cancer activity of ND-646 and its derivatives as acetyl-CoA carboxylase 1 inhibitors.
    Li EQ; Zhao W; Zhang C; Qin LZ; Liu SJ; Feng ZQ; Wen X; Chen CP
    Eur J Pharm Sci; 2019 Sep; 137():105010. PubMed ID: 31325544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).
    Zheng X; Bair KW; Bauer P; Baumeister T; Bowman KK; Buckmelter AJ; Caligiuri M; Clodfelter KH; Feng Y; Han B; Ho YC; Kley N; Li H; Liang X; Liederer BM; Lin J; Ly J; O'Brien T; Oeh J; Oh A; Reynolds DJ; Sampath D; Sharma G; Skelton N; Smith CC; Tremayne J; Wang L; Wang W; Wang Z; Wu H; Wu J; Xiao Y; Yang G; Yuen PW; Zak M; Dragovich PS
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5488-97. PubMed ID: 24021463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice.
    Harada N; Oda Z; Hara Y; Fujinami K; Okawa M; Ohbuchi K; Yonemoto M; Ikeda Y; Ohwaki K; Aragane K; Tamai Y; Kusunoki J
    Mol Cell Biol; 2007 Mar; 27(5):1881-8. PubMed ID: 17210641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy derivatives as selective acetyl-CoA carboxylase 2 inhibitors.
    Gu YG; Weitzberg M; Clark RF; Xu X; Li Q; Zhang T; Hansen TM; Liu G; Xin Z; Wang X; Wang R; McNally T; Zinker BA; Frevert EU; Camp HS; Beutel BA; Sham HL
    J Med Chem; 2006 Jun; 49(13):3770-3. PubMed ID: 16789734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents.
    Imamura K; Tomita N; Kawakita Y; Ito Y; Ono K; Nii N; Miyazaki T; Yonemori K; Tawada M; Sumi H; Satoh Y; Yamamoto Y; Miyahisa I; Sasaki M; Satomi Y; Hirayama M; Nishigaki R; Maezaki H
    Bioorg Med Chem; 2017 Jul; 25(14):3768-3779. PubMed ID: 28571972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal.
    Abu-Elheiga L; Matzuk MM; Kordari P; Oh W; Shaikenov T; Gu Z; Wakil SJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12011-6. PubMed ID: 16103361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conserved mammalian mitochondrial isoform of acetyl-CoA carboxylase ACC1 provides the malonyl-CoA essential for mitochondrial biogenesis in tandem with ACSF3.
    Monteuuis G; Suomi F; Kerätär JM; Masud AJ; Kastaniotis AJ
    Biochem J; 2017 Nov; 474(22):3783-3797. PubMed ID: 28986507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel chroman derivatives as non-selective acetyl-CoA carboxylase inhibitors.
    Wei Q; Mei L; Chen P; Yuan X; Zhang H; Zhou J
    Bioorg Chem; 2020 Aug; 101():103943. PubMed ID: 32554277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mislocalization and inhibition of acetyl-CoA carboxylase 1 by a synthetic small molecule.
    Jung D; Abu-Elheiga L; Ayuzawa R; Gu Z; Shirakawa T; Fujiki Y; Nakatsuji N; Wakil SJ; Uesugi M
    Biochem J; 2012 Dec; 448(3):409-16. PubMed ID: 23067267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W; Wang W; Xu S; Wang J; Tang Q; Wu C; Zhao Y; Zheng P
    Bioorg Med Chem; 2016 Apr; 24(8):1749-56. PubMed ID: 26964675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel olefin derivative as a highly potent and selective acetyl-CoA carboxylase 2 inhibitor with in vivo efficacy.
    Nishiura Y; Matsumura A; Kobayashi N; Shimazaki A; Sakamoto S; Kitade N; Tonomura Y; Ino A; Okuno T
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2498-2503. PubMed ID: 29903660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.